Your browser doesn't support javascript.
loading
Sex and age differences in sST2 in cardiovascular disease.
Beetler, Danielle J; Bruno, Katelyn A; Di Florio, Damian N; Douglass, Erika J; Shrestha, Swikriti; Tschöpe, Carsten; Cunningham, Madeleine W; Krejcí, Jan; Bienertová-Vasku, Julie; Pankuweit, Sabine; McNamara, Dennis M; Jeon, Eun-Seok; van Linthout, Sophie; Blauwet, Lori A; Cooper, Leslie T; Fairweather, DeLisa.
Afiliação
  • Beetler DJ; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.
  • Bruno KA; Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, United States.
  • Di Florio DN; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL, United States.
  • Douglass EJ; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.
  • Shrestha S; Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL, United States.
  • Tschöpe C; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.
  • Cunningham MW; Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, United States.
  • Krejcí J; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL, United States.
  • Bienertová-Vasku J; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.
  • Pankuweit S; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.
  • McNamara DM; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL, United States.
  • Jeon ES; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
  • van Linthout S; Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.
  • Blauwet LA; German Centre for Cardiovascular Research, Berlin, Germany.
  • Cooper LT; Department of Cardiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Fairweather D; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Front Cardiovasc Med ; 9: 1073814, 2022.
Article em En | MEDLINE | ID: mdl-36741845
ABSTRACT

Aims:

The goal of this study was to determine whether sex and age differences exist for soluble ST2 (sST2) for several cardiovascular diseases (CVDs).

Methods:

We examined sST2 levels using an ELISA kit for myocarditis (n = 303), cardiomyopathy (n = 293), coronary artery disease (CAD) (n = 239), myocardial infarct (MI) (n = 159), and congestive heart failure (CHF) (n = 286) and compared them to controls that did not have CVDs (n = 234).

Results:

Myocarditis occurred in this study in relatively young patients around age 40 while the other CVDs occurred more often in older individuals around age 60. We observed a sex difference in sST2 by age only in myocarditis patients (men aged 38, women 46, p = 0.0002), but not for other CVDs. Sera sST2 levels were significantly elevated compared to age-matched controls for all CVDs myocarditis (p ≤ 0.0001), cardiomyopathy (p = 0.0009), CAD (p = 0.03), MI (p = 0.034), and CHF (p < 0.0001) driven by elevated sST2 levels in females for all CVDs except myocarditis, which was elevated in both females (p = 0.002) and males (p ≤ 0.0001). Sex differences in sST2 levels were found for myocarditis and cardiomyopathy but no other CVDs and were higher in males (myocarditis p = 0.0035; cardiomyopathy p = 0.0047). sST2 levels were higher in women with myocarditis over 50 years of age compared to men (p = 0.0004) or women under 50 years of age (p = 0.015). In cardiomyopathy and MI patients, men over 50 had significantly higher levels of sST2 than women (p = 0.012 and p = 0.043, respectively) but sex and age differences were not detected in other CVDs. However, women with cardiomyopathy that experienced early menopause had higher sST2 levels than those who underwent menopause at a natural age range (p = 0.02).

Conclusion:

We found that sex and age differences in sera sST2 exist for myocarditis, cardiomyopathy, and MI, but were not observed in other CVDs including CAD and CHF. These initial findings in patients with self-reported CVDs indicate that more research is needed into sex and age differences in sST2 levels in individual CVDs.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article